Status:
COMPLETED
Pharmacogenomic Analysis of Samples From Subjects in Study RN1004-0082
Lead Sponsor:
Renovo
Conditions:
Wound
Eligibility:
All Genders
18-85 years
Brief Summary
The objective of the study is to identify variations in subjects genetic makeup that segregate responders from non-responders in respect of response to Juvidex in the clinical trial RN1004-0082
Detailed Description
Injury to the skin results in the physical disruption of the normal cellular architecture and triggers wound healing: a process involving inflammation, cell proliferation and migration, cell recruitme...
Eligibility Criteria
Inclusion
- Subjects aged 18-85 years who have given written informed consent.
- Subjects have given written informed consent to participate in the study RN1004-0082.
Exclusion
- Subjects who are not participating in the study RN1004-0082.
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2008
Estimated Enrollment :
195 Patients enrolled
Trial Details
Trial ID
NCT00663780
Start Date
February 1 2008
End Date
September 1 2008
Last Update
January 6 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Trials Unit, Renovo Limited
Manchester, United Kingdom, M13 9XX